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Abstract 
 
Background: Smoking and alcohol consumption have a negative effect on overall health. Limited 
evidence has been presented as to how these health behaviours may change between pre- and post-
operative intervals in the initial 12 months post-arthroplasty. The purpose of this study was to address 
this uncertainty.  
 
Hypothesis: Smoking and alcohol consumption differs between pre- and post-THA/TKA and is differs 
between non-arthroplasty cohorts. 
 
Materials and Methods: Data from the Osteoarthritis Initiative (OAI), a population-based 
observational study in the USA, was gathered. In total, data from 287 people who had undergone THA 
or TKA from baseline to Month 48 OAI follow-up assessments were analysed. Data on this cohort were 
compared to 287 age- and gender-matched people with osteoarthritis. Mean change from pre- to post-
arthroplasty, and differences between arthroplasty and non-arthroplasty participants for smoking and 
alcohol consumption were assessed descriptively and through Wilcoxin-matched pairs test and Student 
t-tests (as appropriate),.  
 
Results: The life-time prevalence of smoking was high for people who received THA (99%) and TKA 
(96%). Prevalence of current smoking significantly decreased from 5% to 3% across the THA and TKA 
cohort in the initial 12 months post-arthroplasty (p<0.05). Similarly, there was a statistically significant 
decrease in weekly alcohol consumption post-arthroplasty for people who underwent THA and TKA 
(p<0.01), although the mean difference was only by 0.9 alcoholic drinks. The only statistically 
significant difference in smoking and alcohol consumption for arthroplasty to non-arthroplasty 
participants was in weekly alcohol consumption, which was higher by 0.3 drinks in the non-arthroplasty 
cohort (p=0.04). 
 
Conclusions: Smoking and alcohol consumption decreased in the initial 12 months post-THA and 
TKA. This was not significantly different to an age- and gender-matched non-arthroplasty cohort. 
Whilst this is positive, a small group of patients still present with unhealthy lifestyle choices in relation 
to these behaviours post-arthroplasty.  
 
Level of Evidence: Level III – Prospective cohort study. 
 
Keywords: joint replacement; alcohol consumption; smoking; complication; morbidity  
 
3 
 
Introduction 
 
Osteoarthritis is the leading cause of musculoskeletal pain and disability in older people [1,2]. Joint 
replacement or arthroplasty is considered the treatment of choice for end-stage osteoarthritis [3]. It has 
been shown to effectively improve pain, function and quality of life for this population [4]. The mean 
age of hip (THA) and knee joint arthroplasty (TKA) range from 67 to 69 years across the literature [5]. 
Consequently, this older age group often present with medical morbidities such as diabetes, 
cardiovascular disease, anxiety and depression [6].  
 
Within developed countries, there remains a high proportion of people in this age group who smoke 
and drink alcohol [7]. It has been estimated that between 8% to 25% of people aged 60 to 70 years old 
are cigarette smokers [7]. Alcohol consumption in excess of recommended daily limits has been 
estimated to present in 14% of 65 to 74 year olds and 15% in those aged 75 years or over [8]. It remains 
unclear whether these figures represent people who undergo THA or TKA.  
 
Smoking and alcohol consumption have been acknowledged to adversely affect post-operative 
outcomes [9]. For instance, these behaviours may be associated with increased revision and 
complication rates after THA and TKA, most notably increasing the risks of pneumonia, stroke, urinary 
tract infection (UTI) and overall mortality [9]. However limited evidence has been presented on how 
these health behaviours may alter after arthroplasty and principally in the initial 12 months post-
operative when this population most frequently come into contact with healthcare professionals. 
Accordingly, the purpose of this study was in two-parts. Firstly we aimed to determine what was the 
pre- and post-operative smoking and alcohol consumption for people who undergo THA or TKA and 
to explore whether this changes within the first year post-operatively. Secondly we aimed to compare 
smoking and alcohol consumption for people post-arthroplasty to an age- and gender-matched cohort 
of people with osteoarthritis who have not undergone THA or TKA.   
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Methods 
Osteoarthritis Initiative Dataset 
Data used in the preparation of this article were obtained from the Osteoarthritis Initiative (OAI) 
database, which is available for public access at http://www.oai.ucsf.edu/. The OAI is a large-scale, 
multi-centre (four sites across the USA), longitudinal cohort study aimed to investigate the role of 
biomarkers in the development and progression of lower limb osteoarthritis. 
Data has been collected longitudinally from baseline to 84 months. Data collected included individual's 
demographic characteristics, previous and current medical history, pharmacological requirements and 
practices, diet, lifestyle and physical activity. For this analysis, data were identified from all datasets 
from baseline to Month 48 as these follow-up intervals collected data on smoking and alcohol 
consumption from participants. 
 
Cohort 
The cohort of interest were people who had undergone THA or TKA, with a minimum of 12 month 
post-arthroplasty, from the baseline to Month 48 OAI follow-up assessments. Since this study was 
interested in individual’s smoking and alcohol consumption and its change over time, rather than the 
specific arthroplasty per se, where people had undergone multiple arthroplasty procedures within the 
OAI follow-up period, data from the first arthroplasty procedure were analysed to avoid multiplicity. 
For comparison, we identified the same number of individuals who had hip or knee osteoarthritis, 
closely matched for age and gender, but who had not undergone a THA or TKA. These individuals 
were therefore used as a ‘reference group’ to assess smoking and alcohol consumption as a normative 
comparison. 
 
Outcomes 
 
The outcomes of interest were smoking and alcohol consumption. The self-reported data used to answer 
these questions included: “have you smoked at least 100 cigarettes (five packs) in entire life”; “how old 
when first started smoking cigarettes fairly regularly”; “how old when first started smoking cigarettes 
fairly regularly”; “have you ever smoked cigarettes regularly”; “on average of entire time have 
smoked”, “how many cigarettes did usually smoke per day”; “do you currently smoke cigarettes”; “ 
how many pipes, cigars or cigarillos do you smoke per week”; “how older were you when you stopped 
smoking pipe, cigars or cigarillos”; “how much alcohol do you consume in typical week in past 12 
months”; “have you ever drunk more beer, wine or liquor than you do now”; and the calculated pack-
years of smoking cigarettes. Demographic characteristics of: age at arthroplasty, gender, ethnic origin, 
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height at age 25, weight at aged 25, maximum adult weight, minimum adult weight and arthroplasty 
procedure (THA or TKA), were extracted from the OAI dataset. 
 
Data analysis 
Participant characteristic and data at baseline and Month 48 follow-up assessments were assessed using 
descriptive statistics (frequencies and mean/standard deviation (SD) values). To assess change in 
smoking and alcohol consumption between pre- and post-arthroplasty and for the non-arthroplasty 
reference group, data were analysed using a Wilcoxin-matched pairs test or Student paired t-test 
(dependent on data normality), and presented with mean differences and p-values with 95% confidence 
intervals. To compare smoking and alcohol consumption to a normative group, we compared each 
measure of smoking and alcohol consumption between the arthroplasty and the non-arthroplasty 
reference group using a Mann Whitney U-Test or Student t-test for continuous data and Fishers Exact 
Test for categorical data at Month 48 follow-up assessments. A p-value of less 0.05 was considered 
statistically significant. All analyses were undertaken using STATA version 14.0 (STATACorp LP, 
Texas, USA). 
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Results 
Cohort Characteristics 
 
Figure 1 illustrates the participant selection based on an a priori eligibility criteria. From the initial 
4796, 287 individuals were identified as having undergone THA or TKA between baseline to Month 
48 follow-up, with data on smoking and alcohol consumption and a minimum 12 month post-operative 
interval. This included 70 people who had undergone THA and 217 TKA. These were compared to 287 
individuals who had a physician-made (clinical and/or radiological) diagnosis of hip (n=70) or knee 
(n=217) osteoarthritis, but had not undergone THA or TKA.  
 
The demographic characteristics of the cohorts are presented in Table 1. The mean age at arthroplasty 
was 69.0 years (THA: 66.1; TKA: 69.9). The arthroplasty cohort consisted of 117 males and 170 
females (THA: 30/40; TKA: 87/130). The non-arthroplasty reference group consisted of 114 males and 
173 females, with a mean age of 67.7 years. Table 2 demonstrates the baseline (pre-arthroplasty) 
smoking and alcohol behaviours for the THA, TKA and non-arthroplasty group.  
 
Smoking 
  
The change in smoking habit between pre-arthroplasty (baseline) and post-arthroplasty (Month 48) is 
presented in Table 3 and Table 4. There was a statistically significant difference in the number of current 
smokers from pre- to post-THA (10.0% to 5.7%) or TKA (3.7% to 2.3%; p≤0.01), and a significant 
decrease in the number of cigarette smokers from pre- to post-THA (p=0.01) and TKA (p<0.01). This 
decrease was only by three individuals in each cohort. There was also a decrease in the number of 
individuals who smoked a pipe, cigar or cigarillos from pre-arthroplasty to post- (THA: p=0.02; TKA: 
p=0.02). Again this decrease was only by a single individual in each cohort. There was no statistically 
significant change in mean number of cigarettes, pipes, cigars or cigarillos smoked for the THA and 
TKA groups from pre- to post-arthroplasty assessments (p≥0.07). There was no statistically significant 
difference in smoking habit between the THA or TKA cohorts compared to the non-arthroplasty 
reference group at post-arthroplasty assessment (Table 5; p>0.05). 
 
Alcohol Use 
 
The change in alcohol consumption between pre-arthroplasty (baseline) and post-arthroplasty (Month 
48) is presented in Table 3 and Table 4. There was a statistically significant difference in alcohol 
consumption between pre- and post-arthroplasty (p<0.01). People following THA or TKA reduced their 
alcohol consumption, with a statistically significant decrease in the number of alcoholic drinks typically 
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taken per week in the overall arthroplasty cohort (p<0.01) and specifically the TKA (p=0.01). There 
was no statistical difference in alcohol consumption in the THA cohort (p=0.49). The absolute 
differences were small with a mean difference of 0.1 drinks in the THA and 0.2 in the TKA cohort 
(Table 4). There was a statistically significant decrease in the number of people who reported ever 
drinking more alcohol now than previously, with this reducing from 124 to 109 participants in the 
overall arthroplasty cohort (p<0.01). Whilst statistically significant, this decrease was by three 
participants in the THA cohort and 12 in the TKA cohort. There was a statistically significant decrease 
in the number of alcoholic drinks typically taken per week in the TKA cohort compared to the non-
arthroplasty cohort (p<0.04), although only by 0.3 drinks per week. There was no statistically significant 
difference between this measure for the THA group (p=0.18). There was also no statistically significant 
difference between the THA or TKA cohorts compared to the non-arthroplasty group for the number of 
people who reported ever drinking more alcohol now than previously (p≥0.79; Table 5). 
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Discussion 
 
The findings of this study indicate the life-time prevalence of smoking was very high for people who 
later underwent THA or TKA. This significantly reduced post-arthroplasty with an overall prevalence 
of 3%. Similarly there was a significant, but small, decrease in alcohol consumption post-arthroplasty 
in this arthroplasty cohort. However, there was no statistically significant difference in smoking and 
alcohol behaviours for people post-arthroplasty compared to an age- and gender-matched cohort of 
people with osteoarthritis who had not undergone arthroplasty. This suggests that the changes seen 
between pre- and post-THA or TKA are not related to surgery, but are related to ageing or other natural 
differences over time. 
The data suggests that although there is a need to ensure that this population have support and advice 
on smoking cessation and alcohol misuse, these behaviours may be less of a problem than in the wider-
population where smoking and excessive alcohol consumption over recommended levels is estimated 
to be between 14% to 25% for this older age group [7,8]. However type two statistical error caused by 
analysing a small number of individuals who were still smokers at the Month 48 follow-up may be the 
cause for some of the non-statistically significant findings between the THA and TKA cohorts. For 
example, for mean number of alcoholic drinks consumed per week, where the TKA cohort reported a 
statistically significant decrease (p<0.01) whereas this did not reach significance for the THA cohort 
(p=0.49). Nonetheless the quantities of alcohol consumed recorded were under recommended limits of 
alcohol consumption suggesting a low risk to overall health [10,11].  
The results indicate that whilst low, there remains a small proportion of people before and after THA 
or TKA who smoke. Previous literature has identified that this can have a detrimental effect on clinical 
outcomes, particularly within the initial six months post-arthroplasty [9]. Accordingly, strategies are 
required to support and counsel people on these disadvantages to maximise their clinical outcome 
following these orthopaedic procedures [10]. Through this, consideration should be made to support the 
adoption of interventions, and to encourage this population to change lifestyles post-operatively, as this 
could have longer-term implications on their general health and well-being given the association of 
smoking and cardiovascular disease and cancer [11-13]. Clinicians are therefore supported to consider 
the adoption of smoking cessation advice to educate and support their patients to change lifestyles in 
promoting future health. 
 
Whilst these findings suggest that smoking and alcohol behaviours in THA and TKA cohorts are similar 
to non-arthroplasty participants from the OAI dataset, it remains unclear why this specific population 
presented with lower levels of smoking and alcohol consumption compared to the wider general 
population. Hypotheses include the possibility that this population have greater contact with healthcare 
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professionals who may have instilled health promotion strategies on smoking and alcohol consumption 
within their initial 12 post-operative months. For instance, counselling from these individual’s surgeons 
on the known complications of smoking and alcohol, may have caused behaviour change. Alternatively, 
the arthroplasty procedure, with a reduction in pain and functional limitation, may empower and 
motivate this population to live better, healthier lifestyles post-operatively, thereby individuals may 
take the initiative and responsibility for their health. Finally, all participants in the OAI dataset 
volunteered to participate in this observation study. Therefore it may be that this is a self-selecting group 
of the population who are not ‘typical’ of the wider population. These all remain speculative and further 
explorative research is required to better understand whether attitudes and experiences of this 
population differ to the wider population. 
Previous studies have explored the impact of significant alcohol misuse as opposed to determining 
overall ‘normative’ data on people following arthroplasty. For instance, Best et al’s [14] cohort from 
the North American National Hospital Discharge Survey reported the association between alcohol 
misuse and surgery-related and general medical complications. Whilst this provided valuable data on 
the ‘misuse’ population, it provided limited insight into those people who consume alcohol but either 
less frequently in ‘binges’ or at sub-misuse levels. Furthermore, there remains uncertainty within the 
literature on the consequences of alcohol consumption or smoking on longer-term surgical outcomes, 
and whether this changes over time with modifications in people’s lifestyles post-arthroplasty. Further 
longitudinal studies assessing medical morbidities, and the incidence of adverse events such as falls and 
perceptions of smoking and alcohol consumption in the recovery following THA and TKA are 
considered important to better understand the theoretically underpinning involved with these behaviours 
in this population.  
 
This study raises three important limitations. Smoking and alcohol consumption data from the OAI 
dataset was self-reported. Consequentially these data may have been influenced by systematic errors in 
individual’s capability to recall their previous smoking and alcohol consumption or potentially 
purposeful under-reporting of consumption due to social desirability biases, and not wanting to release 
information on these lifestyle behaviours. Such a phenomena has been previously reported within the 
literature [15,16]. Secondly, the OAI database is a cohort of people from North America. Whilst this 
provides valuable data, there may be reduced generalisability to other developed countries as well as to 
developing nations. This is important given the differences in smoking and alcohol consumption 
reported particularly in developing countries where these are growing in prevalence [17,18]. Such 
countries have also seen significant increases in arthroplasty procedures during the past 10 years [19]. 
Therefore the generalisability of these findings to other populations should be considered with caution. 
Finally, no data were provided from this dataset on health resources or interventions which individuals 
may have attended which may have accounted for the low prevalence of smokers and drinkers in the 
10 
 
cohorts. It is unclear whether some patients analysed in the arthroplasty cohort had counselling or 
therapy pre-operatively to aid alcohol reduction or smoking cessation. Therefore the results on lifestyle 
change may be attributed to health service interventions rather than individual initiatives. Recording 
such information in future cohort datasets on this topic would therefore be a valuable addition to better 
contextualise the results from this analysis. 
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Figure and Table Legends 
 
Figure 1: Flow-chart illustrating the participant selection based on a priori eligibility criteria.  
 
Table 1: Demographic characteristics 
Table 2: Baseline smoking and alcohol consumption characteristics. 
Table 3: Changing smoking and alcohol consumption between baseline and Month 48 data. 
Table 4: Inferential analyses to assess the statistical difference between baseline and Month 48 for 
smoking and alcohol consumption for each group. 
Table 5: Inferential analyses to assess the statistical difference between THA and TKA cohorts and 
the normative non-arthroplasty cohort for smoking and alcohol consumption. 
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Figure 1: Flow-chart illustrating the participant selection based on a priori eligibility criteria
Total OAI dataset 
(N=4796) 
Individual THA or TKA 
participants  
(N=287) 
Individual THA 
participants  
(N=110) 
Non-THA/TKA datasets 
(N=4509) 
Individual TKA 
participants  
(N=177) 
Osteoarthritic (non-arthroplasty) 
participants 
(N=287) 
Matched 
Subset 
15 
 
Table 1: Demographic characteristics 
 
 Total 
Arthroplasty 
Cohort 
THA TKA Normative 
Cohort 
N 287 70 217 287 
Mean age at arthroplasty in 
years (SD) 
69.0 (33.2) 66.1 (9.7) 69.9 (37.8) 67.7 (8.59) 
Gender (m/f) 117/170 30/40 87/130 114/173 
Race     
      Non-white 4 1 3 6 
      Caucasian 232 57 175 226 
      African-American 49 12 37 52 
      Asian 2 70 2 3 
Mean height at aged 25 in 
meters (SD) 
1.66 (0.2) 1.70 (0.9) 1.66 (0.3) 1.68 (0.1) 
Mean weight at aged 25 in kg 
(SD) 
67.8 (12.9) 88.1 (13.7) 67.8 (13.2) 64.8 (12.3) 
Maximum adult weight in kg 
(SD) 
88.1 (16.2) 63.7 (11.0) 88.2 (16.9) 82.5 (16.9) 
Minimum adult weight in kg 
(SD) 
62.5 (11.3) 67.8 (12.3) 62.2 (11.4) 60.2 (11.4) 
 
F – female; kg- kilograms; M – Males; N – number; SD – standard deviation; THA – total hip arthroplasty;  
TKA – total knee arthroplasty
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Table 2: Baseline smoking and alcohol consumption characteristics. 
 
 
Total 
Arthroplasty 
(N=287) 
THA 
(N=70) 
TKA 
(N=217) 
Normative 
(N=287) 
Smoked at least 100 cigarettes (5 packs) 
in entire life (Y)  
147/113 34/30 113/83 140/140 
Mean age when first started smoking 
cigarettes fairly regularly (SD)  
17.4 (3.94) 17.6 (3.41) 17.4 (4.15) 18.4 (4.20) 
Ever smoked cigarettes regularly (Y/%) 277 (96.5) 69 (98.6) 208 (95.9) 276 (96.2) 
Of entire time have smoked, number of 
cigarettes smoked per day 
17.9 (13.5) 21.5 (17.3) 16.6 (11.7) 15.7 (10.0) 
Current cigarette smoker (Y/%) 9 (3.1) 4 (5.7) 5 (2.3) 17 (5.9) 
Mean current number of cigarettes smoke 
per day (SD) 
10.4 (5.8) 12 (5.4) 9.2 (6.5) 13.8 (14.3) 
Mean age when stopped smoking (SD) 40.0 (12.0) 40.5 (11.9) 39.3 (12.0) 40.3 (12.8) 
Mean pack-years of smoking cigarettes 
(SD) 
9.1 (17.5) 12.8 (23.8) 7.9 (14.8) 9.2 (15.5) 
Ever smoked pipe, cigars or cigarillos 
(Y/%) 
56 (19.5) 15 (21.4) 41 (18.9) 52 (18.1) 
Mean age when first started smoking 
pipe, cigars or cigarillos fairly regularly 
(SD) 
26.0 (12.5) 26.0 (12.9) 26.2 (11.9) 26.2 (11.0) 
Ever smoked pipes, cigars or cigarillos 
regularly (Y/%) 
20 (7.0) 4 (5.7) 16 (7.4) 21 (7.3) 
Currently pipe, cigars or cigarillos 
smoker (Y/%) 
7 (2.4) 2 (2.9) 5 (2.3) 6 (2.1) 
Mean number of pipes, cigars or 
cigarillos smoke per week (SD) 
4.3 (4.9) 8 (9.9) 3 (2.6) 15.8 (17.0) 
Mean age when stopped smoking pipe, 
cigars or cigarillos (SD) 
36.5 (13.2) 33.9 (12.7) 37.4 (13.5) 36.8 (13.8) 
Mean number of alcoholic drinks in 
typical week in past 12 months (SD) 
1.41 (1.44) 1.73 (1.70) 1.31 (1.34) 1.8 (1.5) 
Ever drink more beer, wine or liquor than 
do now (Y/%) 
110 (38.3) 26 (37.1) 84 (38.7) 116 (40.4) 
 
N – number; P – probability value; SD – standard deviation; THA – total hip arthroplasty; TKA - total knee 
arthroplasty; Y - yes  
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Table 3: Changing smoking and alcohol consumption between baseline and Month 48 data. 
 
Baseline Month 48 
Total 
(N=287) 
THA 
(N=70) 
TKA 
(N=217) 
Norm 
(N=287) 
Total 
(N=287) 
THA 
(N=70) 
TKA 
(N=217) 
Norm 
(N=287) 
Current cigarette 
smoker (Y/%) 
15 (5.3) 7 (10) 8 (3.7) 17 (5.9) 9 (3.1) 4 (5.7) 5 (2.3) 10 (3.5) 
Mean current 
number of 
cigarettes smoke 
per day (SD) 
16.8 
(14.0) 
23 
(19.4) 
13.9 
(6.0) 
13.8 
(14.3) 
10.4 
(5.8) 
12 
(5.4) 
9.2 (6.5) 7.8 (5.9) 
Current pipe, cigar 
or cigarillo smoker 
(Y/%) 
9 (3.1) 3 (4.3) 6 (2.8) 6 (2.1) 7 (2.8) 2 (2.9) 5 (2.3) 4 (1.4) 
Mean number of 
pipes, cigars or 
cigarillos smoke 
per week (SD) 
16 
(18.2) 
22 
(17.1) 
13 
(19.6) 
15.8 
(17.0) 
4.3 (4.9) 8 (9.9) 3 (2.6) 1 (9.0) 
Mean number of 
alcoholic drinks in 
typical week in 
past 12 months 
(SD) 
1.71 
(1.52) 
2.01 
(1.82) 
1.62 
(1.39) 
1.8 (1.5) 1.41 
(1.44) 
1.73 
(1.70) 
1.31 
(1.34) 
1.8 (1.5) 
Ever drink more 
beer, wine or 
liquor than do now 
(Y/%) 
124 
(43.2) 
29 
(13.4) 
95 
(43.8) 
116 
(40.4) 
109 
(38.0) 
26 
(37.1) 
83 
(38.2) 
84 
(22.1) 
 
N – number; P – probability value; SD – standard deviation; THA – total hip arthroplasty; TKA - total knee 
arthroplasty; Y - yes 
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Table 4: Inferential analyses to assess the statistical difference between baseline and Month 48 for 
smoking and alcohol consumption for each group. 
 
 
Total (N=287) THA (N=70) TKA (N=217) Normative 
(N=287) 
MD 
(SD) 
(p-value; 
95% CI) 
MD 
(SD) 
(p-
value; 
95% CI) 
MD 
(SD) 
(p-
value; 
95% CI) 
MD 
(SD) 
(p-value; 
95% CI) 
Current cigarette 
smoker (Y; 
Baseline/Month 48) 
15/9 P<0.001 7/4 P=0.01 8/5 P<0.001 17/10 P<0.001 
Mean current 
number of 
cigarettes smoke 
per day (SD)* 
8.8 
(6.23) 
P=0.04 
(0.03,0.04) 
12.1 
(8.59) 
P=0.17 
(0.18 to -
0.20) 
6.2 
(4.40) 
P=0.07 
(0.07 to -
0.08) 
3.5 
(4.43) 
P=0.20 (-
3.56 to 
10.57) 
Current pipe, cigar 
or cigarillo smoker 
(Y; Baseline/Month 
48) 
9/7 P<0.001 3/2 P=0.02 6/5 P=0.02 6/4 P=0.08 
Mean number of 
pipes, cigars or 
cigarillos smoke per 
week (SD)* 
10.2 
(7.2) 
P=0.06 
(0.07 to -
0.08) 
16.7 
(11.8) 
P=0.10 
(0.25 to -
0.27) 
7.75 
(5.5) 
P=0.32 
(0.38-
0.39) 
12.0 
(10.6) 
P=0.32 (-
0.05 to 
0.10) 
Mean number of 
alcoholic drinks in 
typical week in past 
12 months (SD) 
0.16 
(0.92) 
P=0.006 
(0.05 to 
0.27) 
0.11 
(1.27) 
P=0.49 
(-0.21 to 
0.43) 
0.18 
(0.78) 
P=0.002 
(0.06 to 
0.29) 
-0.06 
(1.31) 
P=0.73 (-
0.23 to 
0.10) 
Ever drink more 
beer, wine or liquor 
than do now (Y; 
Baseline/Month 48) 
124/109 P<0.001 29/26 P<0.001 95/83 P<0.001 116/84 P<0.001 
 
* Wilcoxin-matched pairs test  
CI – confidence interval; MD – mean difference; N – number P – probability value; SD – standard deviation; 
THA – total hip arthroplasty; TKA - total knee arthroplasty; Y - yes 
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Table 5: Inferential analyses to assess the statistical difference between THA and TKA cohorts and 
the normative non-arthroplasty cohort for smoking and alcohol consumption at Month48. 
 
 
THA vs. Normative TKA vs. Normative 
MD 
(SD) 
(p-value; 95% 
CI) 
MD 
(SD) 
(p-value; 95% 
CI) 
Current cigarette smoker (Y; Month 48) 
 
4/10 P=0.59  
 
5/10 P=0.49 
Mean current number of cigarettes smoke per day 
(SD)* 
4.22 
(5.89) 
P=0.20  
(-3.42, 11.86) 
1.42 
(5.90) 
P=0.79  
(-5.98, 8.83) 
Current pipe, cigar or cigarillo smoker (Y; 
Baseline/Month 48) 
2/4 P=0.58  
 
5/4 P=0.60 
Mean number of pipes, cigars or cigarillos smoke 
per week (SD)* 
7.83 
(8.28) 
P=0.98  
(-22.00, 22.51) 
-4.75 
(6.08) 
P=0.52  
(-13.54, 4.04) 
Mean number of alcoholic drinks in typical week 
in past 12 months (SD)* 
0.10 
(1.57) 
P=0.79  
(-0.33, 0.54) 
-0.33 
(1.46) 
P=0.04  
(-0.61, -0.06) 
Ever drink more beer, wine or liquor than do now 
(Y; Baseline/Month 48) 
26/84 P=0.89 83/84 P=0.18 
 
* Wilcoxin-matched pairs test  
CI – confidence interval; MD – mean difference; N – number P – probability value; SD – standard deviation; 
THA – total hip arthroplasty; TKA - total knee arthroplasty; Y - yes 
 
 
 
